X
19
Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is DIGOXIN, with a corresponding application number 40481 and regulatory information .
proudly manufactured in the
approval since 2003-08-21
Sandoz B2B's DIGOXIN INJECTABLE;INJECTION, medication with 0.25MG/ML of DIGOXIN.